The Beauty Health Company (NASDAQ:SKIN – Get Rating) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $19.75.
Several research firms have recently weighed in on SKIN. Cowen dropped their target price on shares of Beauty Health from $20.00 to $15.00 and set an “outperform” rating on the stock in a research report on Thursday, February 16th. Benchmark restated a “buy” rating and set a $23.00 price target on shares of Beauty Health in a report on Tuesday. DA Davidson raised their price target on shares of Beauty Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, March 1st. Piper Sandler decreased their price target on shares of Beauty Health from $16.00 to $15.00 in a report on Friday, December 16th. Finally, The Goldman Sachs Group decreased their price target on shares of Beauty Health from $22.00 to $19.00 and set a “buy” rating for the company in a report on Wednesday, November 23rd.
Institutional Investors Weigh In On Beauty Health
Several institutional investors and hedge funds have recently bought and sold shares of SKIN. Park West Asset Management LLC bought a new stake in Beauty Health in the 3rd quarter valued at $21,369,000. Point72 Asset Management L.P. grew its holdings in shares of Beauty Health by 390.3% in the 3rd quarter. Point72 Asset Management L.P. now owns 1,752,900 shares of the company’s stock worth $20,667,000 after purchasing an additional 1,395,408 shares during the last quarter. Senvest Management LLC grew its holdings in shares of Beauty Health by 35.8% in the 4th quarter. Senvest Management LLC now owns 4,576,111 shares of the company’s stock worth $41,643,000 after purchasing an additional 1,207,216 shares during the last quarter. Marshall Wace LLP grew its holdings in shares of Beauty Health by 6,910.3% in the 3rd quarter. Marshall Wace LLP now owns 1,177,732 shares of the company’s stock worth $13,885,000 after purchasing an additional 1,160,932 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Beauty Health in the 4th quarter worth about $7,730,000. Institutional investors own 78.37% of the company’s stock.
Beauty Health Stock Performance
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- Europe Raises Interest Rates, Should the Fed Follow?
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.